Viewing nowActipio Tablet 30 mg (Pioglitazone Hydrochloride)
Pioglitazone Hydrochloride 33.07mg
Tablet · Prescription medication
Yuhan Corporation

MFDS item code 200806488 · Approved 2008.06.13 · Insurance code 642103080
Improvement of type 2 diabetes (blood sugar control)
This medication is used as an adjunct to diet and exercise to improve blood sugar control in patients with type 2 diabetes. It may be administered as a monotherapy and when there is no improvement in blood sugar with other oral hypoglycemic agents, it is administered in combination with sulfonylureas, metformin, or insulin. Additionally, it is essential for patients with type 2 diabetes to engage in nutritional counseling, weight loss, and exercise therapy, as these efforts are necessary not only for initial treatment but also for sustaining the effects of drug therapy. This medication is used to effectively improve blood sugar control.
This medication is initiated at 15 mg once daily, and may be increased to 30 mg once daily if the effect is insufficient. Maximum dosage should not exceed 30 mg once daily in monotherapy or in combination with sulfonylureas, metformin, or insulin. This drug is administered orally once daily regardless of meals.
There is no experience with the use of this medication in children under 18 years of age; therefore, administration is not recommended.
This medication is used for the treatment of type 2 diabetes and works together with insulin to control blood sugar. However, this medication may impose a burden on the heart in some patients, so it should not be administered to patients with heart failure or a history of heart failure. During treatment with this medication, patients should be monitored closely for symptoms of heart failure such as weight changes, shortness of breath, and swelling, with immediate consultation with a physician if symptoms occur. Additionally, this medication may cause fluid retention leading to edema, so patients with existing edema or at high risk of cardiovascular disease should be especially cautious. Patients with active bladder cancer or a history of bladder cancer should not take this medication either. It is safest not to administer this medication to patients with severe liver or kidney impairment. Women who are pregnant or may become pregnant should avoid using this medication, and premenopausal women should use appropriate contraception as this medication may stimulate ovulation and increase the risk of pregnancy. This medication can increase the risk of hypoglycemia when used in combination with other diabetes medications, so patients should be well aware of hypoglycemia symptoms and dosage adjustments of other medications may be necessary. Regular monitoring of blood glucose and liver function tests should be performed during treatment, and any sudden weight gain, edema, urinary problems, or hematuria should be reported to a physician immediately. Elderly patients or those with weak kidney or liver function should be treated with greater caution, and this medication should be taken once a day regardless of meals, being careful not to double dose the next day if a dose is missed. In case of overdose, appropriate treatment should be administered based on symptoms and the medication should be stored out of the reach of children.
Congestive heart failure, symptoms and signs of heart failure (including excessive and rapid weight changes, shortness of breath, edema), severe edema, hives, liver abnormalities (jaundice), liver failure, severe dermatological reactions (severe rash with fever, blistering, skin peeling, mucosal pain in mouth/eyes), severe allergic reactions, severe neurological symptoms (severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis), difficulty breathing, asthma
Not everyone experiences these, and they can vary from person to person.
This medication should be protected from light and moisture and should be stored between 15 and 30 degrees Celsius, preferably around 25 degrees. This way of storage can help maintain the medication's efficacy for a longer period.
Flat round tablets that are white or gray
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPioglitazone Hydrochloride 33.07mg
Tablet · Prescription medication
Yuhan Corporation

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 33.06mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Hanol Bio Pharma Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication
Kyungdong Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.